Physician profile
Steven Adler
NPI 1972593994
$2,138.06
in general payments reported to CMS, 2019-2025
11 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,087 · 2020: $10.99 · 2021: $349 · 2022: $48.02 · 2023: $370 · 2024: $107 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $1,000.00 | 2019 | |
| Organogenesis INC. | $387.96 | 2019-2025 | Puraply, Puraply Wound Matrix |
| Smith+Nephew, INC. | $269.98 | 2021-2025 | Grafix Pl, Collagenase Santyl, Renasys Go V2 Home |
| Zimmer Biomet Holdings, INC. | $248.29 | 2020-2023 | Ceramentbone Void Filler |
| Polarityte, INC. | $71.35 | 2019 | |
| Integra Lifesciences Corporation | $51.08 | 2021 | |
| Treace Medical Concepts, INC. | $44.60 | 2022-2024 | |
| Convatec INC. | $24.48 | 2025 | |
| Medline Industries LP | $16.24 | 2021 | |
| Bioventus LLC | $12.39 | 2022 | |
| Reprise Biomedical, INC. | $11.69 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.